Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Characterizing the human mitochondrial processing peptidase in neurodegenerative disease

EF 2018-19

Résumé
Neurodegenerative disorders have become one of the most critical health issues, as the world's aging population increases and treatments remain scarce. For most of these disorders, current treatments serve solely as "symptomatic band-aids" given too late in the disease progression. As such, there exists a desperate need to study these disorders from unique avenues to reveal novel points of regulation and other potential drug targets. In our bodies, mitochondria have been typically labelled as the "energy generators" of our cells, however, their importance in the brain and their implications in neurodegenerative disorders have become increasingly apparent over the last 10 years. Today, biologists acknowledge the existence of an intimate link between mitochondrial dysfunction and neurodegeneration. This project will investigate this link through the lens of one specific, overlooked molecular player: the mitochondrial processing peptidase (MPP). Recently, mutations in both MPP and its interactors have been implicated in Parkinson's disease and certain ataxias, yet their underlying mechanisms and neuronal consequences remain uncharacterized. Our work will serve to answer a few key questions: how does MPP contribute to these disorders? Can we study these interactions to design neuroprotective drugs? Our work will lay the foundation for a drug design platform targeting MPP whose effect will be two-fold: first, it will allow us to design research tools for studying basic mitochondrial mechanisms, and second, it will propel the development of therapeutics against MPP-linked neurodegenerative disorders. Our results will also provide new biochemical models to reveal how key mitochondrial functions exert such a unique effect in our brains. Globally, this project will foster collaboration with scientists across the world, and will be directly impactful to researchers, clinicians, and those suffering from neurodegenerative disease alike.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
408148
Name
Bayne Andrew
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Characterizing the human mitochondrial processing peptidase in neurodegenerative disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Ataxia; Mitochondria; Mitochondrial Import; Mitochondrial Processing Peptidase; Mitochondrial Quality Control; Mitophagy; Neurodegeneration; Parkinson'S Disease; Pink1; Structural Biology
Abstract
Neurodegenerative disorders have become one of the most critical health issues, as the world's aging population increases and treatments remain scarce. For most of these disorders, current treatments serve solely as "symptomatic band-aids" given too late in the disease progression. As such, there exists a desperate need to study these disorders from unique avenues to reveal novel points of regulation and other potential drug targets. In our bodies, mitochondria have been typically labelled as the "energy generators" of our cells, however, their importance in the brain and their implications in neurodegenerative disorders have become increasingly apparent over the last 10 years. Today, biologists acknowledge the existence of an intimate link between mitochondrial dysfunction and neurodegeneration. This project will investigate this link through the lens of one specific, overlooked molecular player: the mitochondrial processing peptidase (MPP). Recently, mutations in both MPP and its interactors have been implicated in Parkinson's disease and certain ataxias, yet their underlying mechanisms and neuronal consequences remain uncharacterized. Our work will serve to answer a few key questions: how does MPP contribute to these disorders? Can we study these interactions to design neuroprotective drugs? Our work will lay the foundation for a drug design platform targeting MPP whose effect will be two-fold: first, it will allow us to design research tools for studying basic mitochondrial mechanisms, and second, it will propel the development of therapeutics against MPP-linked neurodegenerative disorders. Our results will also provide new biochemical models to reveal how key mitochondrial functions exert such a unique effect in our brains. Globally, this project will foster collaboration with scientists across the world, and will be directly impactful to researchers, clinicians, and those suffering from neurodegenerative disease alike.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bayne, Andrew
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~